医护人员潜伏性结核治疗接受与完成的影响因素
该研究对某大型学术医学中心10年内入职时发现潜伏性结核感染(LTBI)的470名医护人员进行回顾性病历分析。193人(41.1%)接受治疗,137人(29.1%)完成治疗;4个月利福平方案依从性优于9个月异烟肼方案(95% vs 68%,P < .005)。年龄增长、临床医生或研究者职业与较低接受率相关,男性与较高接受率相关。
要点
- 4个月利福平方案完成率95%,优于9个月异烟肼方案的68%。
- 临床医生与研究者接受LTBI治疗的可能性低于其他岗位医护人员。
- 来自低或中等结核负担国家者治疗完成率更高。
核心结论
- 地理与职业因素影响医护人员LTBI治疗的接受与完成,短程方案可能改善依从性。
- 医生、研究者及来自高结核负担国家的医护人员治疗率低于其他医护人员。
- 改善医护人员LTBI治疗需关注文化与职业差异。
研究设计与样本
- 对某大型学术医学中心10年期间入职时发现LTBI的全部员工进行回顾性病历复习。
- 共纳入470名被推荐治疗的LTBI医护人员。
- 采用多因素logistic回归分析个人人口学、职业因素和门诊就诊变量与治疗接受率及完成率的相关性。
主要发现
- 470名被推荐治疗的医护人员中,193人(41.1%)接受治疗,137人(29.1%)完成治疗。
- 4个月利福平方案的治疗依从性优于9个月异烟肼方案(95% vs 68%,P < .005)。
- 医护人员年龄每增加1岁,治疗接受率独立降低(OR 0.97,95%CI 0.94-0.99)。
- 临床医生(OR 0.47,95%CI 0.26-0.85)与研究者(OR 0.34,95%CI 0.19-0.64)的治疗接受率较低。
- 男性治疗接受率较高(OR 1.90,95%CI 1.21-2.99);来自低结核负担国家(OR 9.49,95%CI 2.06-43.73)或中等结核负担国家(OR 8.51,95%CI 3.93-18.44)与治疗完成相关。
临床怎么用
- 对医护人员LTBI优先考虑短程利福平方案以提高完成率。
- 针对临床医生、研究者及高结核负担国家来源人员加强文化敏感的患者教育与随访。
- 入职筛查发现LTBI后应系统评估职业与文化因素对治疗意愿的影响。
局限性
- 为单中心回顾性病历复习,结果外推需谨慎。
- 仅纳入入职时发现LTBI并被推荐治疗的员工,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: US public health strategy for eliminating tuberculosis (TB) prioritizes treatment of latent TB infection (LTBI). Healthcare personnel (HCP) are less willing to accept treatment than other populations. Little is known about factors associated with HCP LTBI therapy acceptance and completion. METHODS: We conducted a retrospective chart review to identify all employees with LTBI at time of hire at a large academic medical center during a 10-year period. Personal demographics, occupational factors, and clinic visit variables were correlated with LTBI treatment acceptance and completion rates using multivariate logistic regression. RESULTS: Of 470 HCP with LTBI for whom treatment was recommended, 193 (41.1%) accepted treatment, while 137 (29.1%) completed treatment. Treatment adherence was better with 4 months of rifampin than 9 months of isoniazid (95% vs 68%, P < .005). Increased age of the healthcare worker was independently associated with lower rates of treatment acceptance (odds ratio [95% confidence interval]: 0.97 [0.94-0.99] per year), as was having an occupation of clinician (0.47 [0.26-0.85]) or researcher (0.34 [0.19-0.64]). Male gender was associated with higher treatment acceptance (1.90 [1.21-2.99]). Treatment completion was associated with being from a low- (9.49 [2.06-43.73]) or medium- (8.51 [3.93-18.44]) TB-burden country. CONCLUSIONS: Geographic and occupational factors affect acceptance and completion of LTBI therapy. Short-course regimens may improve adherence. Physicians, researchers, and HCP from high-TB-burden countries have lower treatment rates than other HCP. Improving LTBI treatment in HCP will require attending to cultural and occupational differences.
引用
- Swift MD, Molella RG, Vaughn AIS, et al. Determinants of Latent Tuberculosis Treatment Acceptance and Completion in Healthcare Personnel. Clin Infect Dis. 2020. PMID: 31552416. doi:10.1093/cid/ciz817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。